| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-10 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |